Marco Paulli Selected Research

Marco Paulli Research Topics

Disease

37	Neoplasms (Cancer) 05/2023 - 02/2004
19	Lymphoma (Lymphomas) 06/2024 - 02/2003
9	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 05/2023 - 11/2003
5	Microsatellite Instability 01/2023 - 08/2015
5	Carcinoma (Carcinomatosis) 12/2022 - 08/2015
5	Crohn Disease (Crohn's Disease) 12/2022 - 10/2017
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 08/2020 - 09/2002
4	Colorectal Neoplasms (Colorectal Cancer) 02/2021 - 01/2018
4	Celiac Disease (Celiac Sprue) 02/2021 - 01/2016
4	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020 - 06/2011
4	Monoclonal Gammopathy of Undetermined Significance 11/2019 - 03/2013
3	Adenocarcinoma 12/2022 - 11/2020
3	Waldenstrom Macroglobulinemia (Macroglobulinemia) 11/2019 - 02/2011
3	Disease Progression 01/2019 - 12/2009
3	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 07/2013 - 02/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 05/2023 - 04/2018
2	Neoplasm Metastasis (Metastasis) 06/2022 - 01/2018
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 06/2022 - 12/2018
2	Splenomegaly 01/2022 - 11/2019
2	Inflammation (Inflammations) 01/2022 - 05/2020
2	Multiple Myeloma 01/2022 - 11/2003
2	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 11/2013
2	COVID-19 08/2021 - 11/2020
2	Infections 11/2020 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2020 - 02/2009
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 08/2011
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 08/2011
2	Hematologic Neoplasms (Hematological Malignancy) 01/2019 - 01/2012
1	Enteropathy-Associated T-Cell Lymphoma 05/2023
1	Lymphocytosis 05/2023
1	POEMS Syndrome (Syndrome, POEMS) 04/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Skin Manifestations 01/2023
1	Insect Bites and Stings (Insect Bite) 01/2023
1	Turcot syndrome 01/2023
1	Hypersensitivity (Allergy) 01/2023
1	Neurofibromatosis 1 (Neurofibromatosis Type I) 06/2022
1	Neuroendocrine Carcinoma 06/2022
1	Atrophic Gastritis 01/2022
1	Diplopia (Double Vision) 01/2022
1	Paraneoplastic Cerebellar Degeneration 01/2022
1	Coloboma (Colobomas) 01/2022
1	Facies 01/2022
1	Simpson-Golabi-Behmel syndrome 01/2022
1	Polyhydramnios 01/2022
1	Adenoma (Adenomas) 12/2021
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 12/2021
1	Metaplasia 12/2021
1	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 08/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021
1	Leiomyosarcoma 01/2021
1	Myeloid Sarcoma (Chloroma) 12/2020
1	Glandular and Epithelial Neoplasms (Neoplasms, Glandular) 11/2020

Drug/Important Bio-Agent (IBA)

15	Proteins (Proteins, Gene)FDA Link 04/2023 - 09/2002
7	Immunoglobulin M (IgM)IBA 11/2020 - 02/2011
4	Keratin-7 (Cytokeratin 7)IBA 12/2022 - 01/2019
4	DNA (Deoxyribonucleic Acid)IBA 10/2017 - 07/2006
4	Immunoglobulins (Immunoglobulin)IBA 03/2014 - 10/2006
3	CytokinesIBA 01/2023 - 03/2013
3	Antiviral Agents (Antivirals)IBA 12/2022 - 03/2014
3	AntigensIBA 01/2022 - 12/2006
3	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2016
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 06/2022 - 01/2019
2	GlypicansIBA 01/2022 - 08/2015
2	Transcription Factors (Transcription Factor)IBA 11/2020 - 01/2020
2	InterferonsIBA 08/2020 - 01/2004
2	Cadherins (E-Cadherin)IBA 03/2020 - 12/2009
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2016
2	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 12/2018
2	CateninsIBA 12/2018 - 10/2017
2	Death-Associated Protein KinasesIBA 02/2004 - 11/2003
1	5- (benzoylamino)- N- (4- chlorophenyl)- 3- methyl- 4- isothiazolecarboxamide (ITCL)IBA 05/2023
1	ArginaseIBA 01/2023
1	ClaudinsIBA 12/2022
1	Adenosine Monophosphate (AMP)IBA 06/2022
1	Bortezomib (Velcade)FDA Link 01/2022
1	Retinaldehyde (Retinal)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Melphalan (Alkeran)FDA LinkGeneric 01/2022
1	Thymic Stromal LymphopoietinIBA 01/2022
1	polaprezinc (Z 103)IBA 01/2022
1	amsonic acid (DAS)IBA 12/2021
1	Acetylcholine (Acetylcholine Chloride)FDA Link 09/2021
1	MitogensIBA 09/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 09/2021
1	Adalimumab (Humira)FDA Link 08/2021
1	Carrier Proteins (Binding Protein)IBA 11/2020
1	RNA (Ribonucleic Acid)IBA 05/2020
1	Complement System Proteins (Complement)IBA 05/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2020

Therapy/Procedure

12	Therapeutics 12/2022 - 07/2013
9	Drug Therapy (Chemotherapy) 06/2024 - 11/2004
4	Splenectomy 01/2015 - 01/2003
4	Organ Transplantation 05/2010 - 11/2003
2	Lasers (Laser) 10/2015 - 01/2013
1	Immunotherapy 06/2024
1	Adjuvant Chemotherapy 02/2021
1	Chemoradiotherapy 01/2021
1	Ligation 05/2020